Arax Advisory Partners’s Kailera Therapeutics KLRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.31K Buy
+640
New +$10.8K ﹤0.01% 4545

Other funds holding KLRA

Arax Advisory Partners's KLRA Position: Q3 2026 in Review

Arax Advisory Partners opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 640 shares worth $7.31K. The stake represents ﹤0.01% of the portfolio and ranks #4545 among its holdings.

132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

  • Arax Advisory Partners held 640 shares of Kailera Therapeutics worth $7.31K as of Q3 2026.
  • Kailera Therapeutics was a new Arax Advisory Partners position in Q3 2026.
  • Kailera Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #4545 holding.
  • 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.